Anything short of these 3 things mean that there will still be Kentuckians who suffer and possibly die. Money from the “big 3” insulin makers is influencing established advocacy groups across the United States, including some of the testimony heard at the August 21st ommittee meeting. When ideas are proposed that specifically remove blame and accountability from Pharma, it may be a key indicator of who is funding that group. Read more
I got 20 vials of Humalog insulin for $17.40. If you live in the USA, you may be able to, too. Through the little known and vastly underused 340B program, drug makers provide discounted medicine to anyone willing to cut through some red tape. Read more
In September 2019, T1International held our first ever two-day #insulin4all workshop for USA Chapters. The purpose of the workshop was to bring Chapter Leaders together and build their skills and advocating power to push for more affordable, accessible insulin and supplies. About 45 people from about 20 Chapters across the USA came to Indianapolis for the workshop, which included a third annual event outside of Eli Lilly taking the form of a vigil to honor lives lost due to rationing. Read more
It is essential that we change all this. There has to be some way to get insulin, and the best insulin that works for people, at an affordable price for those who need it. Insulin is a life and death situation, not something where if you do not take it you will not be as healthy. My son couldn’t afford his insulin, and he never should have been in that position, but now he’s gone. Read more
Brenda Davis is aware that other young people died in June because they couldn’t get their insulin. “Their deaths are inexcusable,” she said. “Anybody on a lifesaving drug — it should have been approved that day.” She told Kayla’s story because she hopes it can drive change. “This cannot help those other young adults,” said said, “But it might help another diabetic.”
Read more
Andy was quiet but he was always willing to help people. He would give you the shirt of your back if you needed it. I wish that America’s healthcare system was more like Andy, treating everyone with kindness instead of forcing people to go to Canada or go on the black market to get what they need. Read more
The only reason Jesy did not have his insulin – a life dependent drug – was because he couldn’t afford it. He wasn’t lazy. He worked hard, even taking on a second job for some time. Unlike some of the other stories I have heard, Jesy had insurance but the insulin and other supplies were still more than he could afford. The month Jesy died there were four known deaths due to insulin rationing. How many unknown deaths were there? How many deaths will we continue to see before changes are made? Read more
People in the United States of America are dying from type 1 diabetes. For many people, the cost for life saving medications each month is the same as an average months’ rent - or more. How is an average American to afford this? When it comes to type 1 diabetes, people are facing unthinkable decisions – between the costs of living and their very lives – because they live with a non-preventable disease. Read more
I hope Antavia’s story will touch the hearts of the pharmaceutical companies, Congress, and everyone who can help ensure that insulin is affordable to the American people. Living with type 1 diabetes like other chronic illnesses is unaffordable, which forces people into situations where they become noncompliant with managing their care. I hope one day insulin will be as affordable as it is in other high-income countries, and I am glad to add my voice and Antavia’s story to the #insulin4all movement. Read more
At 24 years old, Jada was supposed to have more time. She was supposed to be the maid of honor at her best friend’s wedding. She was supposed to lead the drama ministry at church. She was supposed to give me a niece or nephew a few years down the line. But having no insurance and plenty of bills to pay, my sister was forced to make a choice that would take all of that away from her. Read more